Baumann et al. had confirmed that BEZ235 acted on myeloma cells and induced downregulation of CDC25A, which might be involved in cell cycle G1 phase arrest, thereby inhibiting cell proliferation40. The gene discussed is CDC25A; the disease is plasma cell myeloma.